4.7 Article

Synthesis and biological activity of 1,4-dihydrobenzothiopyrano[4,3-c]pyrazole derivatives, novel pro-apoptotic mitochondrial targeted agents

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 17, Issue 1, Pages 326-336

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2008.10.067

Keywords

Dihydrobenzothiopyranopyrazole; Antiproliferative activity; Mitochondria; Reactive oxygen species; Permeability transition

Funding

  1. MIUR

Ask authors/readers for more resources

This study reports the synthesis of a number of 1- and 2-phenyl derivatives of the 1,4-dihydrobenzothiopyrano[4,3-c]pyrazole nucleus, which were obtained by the reaction of the versatile 7-substituted 2,3-dihydro-3-hydroxymethylene-4H-1-benzothiopyran-4-ones with hydrazine and substituted phenylhydrazines. The antiproliferative activity of the synthesized compounds was evaluated by an in vitro assay on human tumor cell lines (HL-60 and HeLa) and showed a significant capacity of the 7-methoxysubstituted benzothiopyrano[4,3-c]pyrazoles 3b-d, carrying the pendant phenyl group in the 1- position, to inhibit cell growth. Investigation of the mechanism of action indicated the induction of the mitochondrial permeability transition (MPT) as the molecular event responsible for the inhibition of cell growth. This phenomenon is related to the ability of the test compounds to cause a rapid Ca2+-dependent and cyclosporin A-sensitive collapse of the transmembrane potential (Delta Psi) and matrix swelling. All this leads to the release of caspase activators, such as cytochrome c (cyt c) and apoptosis-inducing factor (AIF), which trigger the pro-apoptotic pathway leading to DNA fragmentation. (C) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

trans-Dichloro(triphenylarsino)(N,N-dialkylamino)platinum(II) Complexes: In Search of New Scaffolds to Circumvent Cisplatin Resistance

Mariafrancesca Hyeraci, Laura Agnarelli, Luca Labella, Fabio Marchetti, Maria Luisa Di Paolo, Simona Samaritani, Lisa Dalla Via

Summary: Resistance to cisplatin limits its usefulness as an anticancer drug. This study describes the synthesis and characterization of two new platinum complexes and demonstrates their potential in overcoming cisplatin resistance in cancer cells. The complexes exhibited poor ability to platinate DNA but showed significant intracellular accumulation. Mechanistic studies revealed their ability to inhibit DNA relaxation and activate the apoptotic pathway. Comparison with related complexes provides insights into the resistance phenotype.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

Carbonic Anhydrase Activators for Neurodegeneration: An Overview

Valeria Poggetti, Silvia Salerno, Emma Baglini, Elisabetta Barresi, Federico Da Settimo, Sabrina Taliani

Summary: Carbonic anhydrases (CAs) are important enzymes involved in pH regulation and body fluid balance. Activators of CAs have been identified and may have potential therapeutic applications for neurodegenerative diseases.

MOLECULES (2022)

Article Chemistry, Medicinal

New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: Synthesis and pharmacological effects

Marco Robello, Silvia Salerno, Elisabetta Barresi, Paola Orlandi, Francesca Vaglini, Marta Banchi, Francesca Simorini, Emma Baglini, Valeria Poggetti, Sabrina Taliani, Federico Da Settimo, Guido Bocci

Summary: Novel 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine (BIT) derivatives were designed and synthesized, showing antiproliferative activity against human colorectal adenocarcinoma cells and human dermal microvascular endothelial cells. The most active compounds, 2-4 and 8, target the microtubule cytoskeleton and induce dense microtubule accumulation at the periphery of cancer cells.

ARCHIV DER PHARMAZIE (2022)

Article Integrative & Complementary Medicine

Complementary and Integrative Approaches to Cancer: A Pilot Survey of Attitudes and Habits among Cancer Patients in Italy

Massimo Bonucci, Andrea Geraci, Dina Pero, Cristina Villiva, Daniele Cordella, Maria Condello, Stefania Meschini, Laura Del Campo, Franco Tomassi, Alessandro Porcu, Francesco De Lorenzo, Francesco Lozupone

Summary: The use of traditional, complementary, integrative, and alternative medicine (TCIM) is common among cancer patients, with natural products and mind-body practices being the most commonly used. The main reasons for using TCIM are to alleviate treatment side effects and improve the patients' physical and mental well-being. However, patients often use natural products without consulting a doctor, leading to inappropriate use.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)

Review Oncology

Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors

Maria Condello, Gloria D'Avack, Enrico Pierluigi Spugnini, Stefania Meschini

Summary: Electrochemotherapy is an innovative strategy to tackle multidrug resistance in cancer, enhancing the uptake of chemotherapeutic agents into tumors and potentially improving treatment outcomes.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture

Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Valeria Mazzi, Armando Patrizio, Simona Piaggi, Enke Baldini, Marco Centanni, Concettina La Motta, Alessandro Antonelli, Poupak Fallahi

Summary: This study evaluated the antineoplastic effect of multitarget tyrosine kinase inhibitor pazopanib in primary human anaplastic thyroid cancer cells in vitro. The results showed that pazopanib inhibited cell proliferation, migration, and invasion, and increased apoptosis. Moreover, pazopanib significantly decreased the expression of VEGF in the cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles

Eleonora Colombo, Davide Andrea Coppini, Laura Polito, Umberto Ciriello, Giuseppe Paladino, Mariafrancesca Hyeraci, Maria Luisa Di Paolo, Giulia Nordio, Lisa Dalla Via, Daniele Passarella

Summary: Cannabidiol (CBD), a compound found in Cannabis plants, is shown to be an effective inducer in the formation of nanoparticles. These nanoparticles, formed through solvent displacement, exhibit monodisperse and stable structures. They show low micromolar range cytotoxicity on human tumor cell lines, with the involvement of paclitaxel confirmed in the most effective nanoparticle (NP 8B) through further biological assays.

MOLECULES (2023)

Review Biochemistry & Molecular Biology

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview

Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Sabrina Taliani, Federico Da Settimo

Summary: G-quadruplex (G4)-targeting compounds and Topo inhibitors are promising strategies to target tumor cells. Simultaneous stabilization of G4 and inhibition of Topos can enhance antiproliferative activity and overcome cellular insensitivity and resistance. Some chemotypes with dual activity and interesting pharmacological profile have been identified, but research in this field is still limited.

BIOMEDICINES (2022)

Article Biochemistry & Molecular Biology

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment

Sara Boumya, Silvia Fallarini, Sonia Siragusa, Giovanni Petrarolo, Silvio Aprile, Valentina Audrito, Concettina La Motta, Silvia Garavaglia, Laura Moro, Giulia Pinton

Summary: Aldehyde dehydrogenase 1A3 (ALDH1A3) has been linked to poor prognosis in malignant pleural mesothelioma (MPM). Inhibition of ALDH1A3 using NR6 resulted in the accumulation of toxic aldehydes, DNA damage, CDKN2A expression, and cell growth arrest. NR6 treatment also affected the tumor microenvironment by altering IL6, CXCL8, and IL-8 levels, and shifting cell fate from senescence to apoptosis. Understanding the role of ALDH1A3 in MPM cells and the tumor microenvironment could lead to potential new treatments for this cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents

Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Federico Da Settimo, Sabrina Taliani

Summary: Glioblastoma (GBM) is a highly aggressive and common primary brain tumor with a poor prognosis and high mortality rate. Current treatment options, including surgical resection, radiotherapy, and chemotherapy, have limited efficacy. This review focuses on the therapeutic benefits and clinical development of novel indole-based derivatives as potential anti-GBM agents. It discusses the current pre-clinical and clinical stage compounds, emphasizing the recent advances between 2013 and 2022. The mechanisms of action, such as protein kinase, tubulin, and p53 pathway inhibition, are also analyzed.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs

Giulia Nordio, Francesco Piazzola, Giorgio Cozza, Monica Rossetto, Manuela Cervelli, Anna Minarini, Filippo Basagni, Elisa Tassinari, Lisa Dalla Via, Andrea Milelli, Maria Luisa Di Paolo

Summary: Monoamine oxidases (MAOs) have been widely studied in neurological diseases, but recent research has discovered their potential role in certain types of cancer. This study identified novel MAO inhibitors with antiproliferative activity, suggesting their potential as anticancer agents.

MOLECULES (2023)

Article Pharmacology & Pharmacy

New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease

Lidia Ciccone, Caterina Camodeca, Nicolo Tonali, Lucia Barlettani, Armando Rossello, Carole Fruchart Gaillard, Julia Kaffy, Giovanni Petrarolo, Concettina La Motta, Susanna Nencetti, Elisabetta Orlandini

Summary: A series of new hybrid derivatives inspired by nature were synthesized and studied as multifunctional agents for the treatment of Alzheimer's disease. These compounds combine bioactive moieties with the ability to chelate biometals and exhibit antioxidant activity.

PHARMACEUTICS (2023)

Review Chemistry, Medicinal

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry

Elisabetta Barresi, Marco Robello, Emma Baglini, Valeria Poggetti, Monica Viviano, Silvia Salerno, Federico Da Settimo, Sabrina Taliani

Summary: In recent years, indolylglyoxylamide-based derivatives have been extensively studied for their potential in drug design and discovery, resulting in a wide range of compounds with diverse pharmacological activities. This review focuses on the elegant utilization of the indolylglyoxylamide moiety by medicinal chemists to develop potential drugs, particularly those showing in vivo activity or undergoing clinical trials. The information provided in this review offers valuable insights and perspectives for further research and design of indolylglyoxylamide-based molecules with promising pharmacological profiles.

PHARMACEUTICALS (2023)

Article Chemistry, Inorganic & Nuclear

Dibromo- and Dichlorotriphenylphosphino N-Acyclic Carbene Complexes of Platinum(II)-Synthesis and Cytotoxicity

Anna Farasat, Luca Labella, Maria Luisa Di Paolo, Lisa Dalla Via, Simona Samaritani

Summary: This study synthesized a series of new N-acyclic carbene and isonitrile complexes of platinum(II). Among them, NAC derivatives showed a moderate cytotoxic effect on MSTO-211H cells.

INORGANICS (2023)

Article Pharmacology & Pharmacy

Hepatoprotective Activity, In Silico Analysis, and Molecular Docking Study of Verbascoside from Leucophyllum frutescens in Rats with Post-Necrotic Liver Damage

Osmar Antonio Jaramillo-Morales, Erik Diaz-Cervantes, Lisa Dalla Via, Aida Nelly Garcia-Argaez, Josue Vidal Espinosa-Juarez, Jose Carlos Ovando-Zambrano, Victor Manuel Munoz-Perez, Carmen Valadez-Vega, Mirandeli Bautista

Summary: The study aimed to evaluate the hepatoprotective effect of verbascoside on liver damage induced by thioacetamide and demonstrated that verbascoside can interact with a cancerous target, reducing liver injury.

SCIENTIA PHARMACEUTICA (2023)

No Data Available